Sato Shigeki, Tanimoto Azusa, Yanagimura Naohiro, Suzuki Chiaki, Takumi Yohei, Nishiyama Akihiro, Yamashita Kaname, Takeuchi Shinji, Ohtsubo Koushiro, Makino Tomoe, Yoshida Yoshio, Hirono Yasuo, Hayashi Ryuji, Koizumi Tomonobu, Nakazawa Yozo, Ito Ken-Ichi, Motoo Yoshiharu, Uramoto Hidetaka, Nakada Mitsutoshi, Nishino Yoshikazu, Yano Seiji
Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 13-1, Takara-machi, Kanazawa, Ishikawa, 920-0934, Japan.
Division of Adult Nursing Practice, Ishikawa Prefectural Nursing University, Kahoku, Japan.
Int J Clin Oncol. 2021 Jun;26(6):1009-1014. doi: 10.1007/s10147-021-01890-3. Epub 2021 Mar 1.
Potential disparities between cancer patients with and without disabilities remained to be validate in Japan.
We surveyed retrospective data on hospital cancer registration as well as information on disability certificates obtained through the Hokushin Ganpro database. In total, 93,545 cancer patients in 10 principal hospitals covering the region of northwestern Japan were registered with the Hokushin Ganpro database between 2010 and 2015. The database included the following data: diagnosis date, cancer type, staging, treatment, cancer detection process, and possession of a disability certificate.
We found that 2983 patients, which accounted for 3.2% of the total patients, had disabilities. No significant differences in gender, age at diagnosis, cancer stage distribution, and cancer incidence rates were observed between the disabled and non-disabled patients. Even though the proportion of early-stage cancer among disabled patients differed only slightly from that in non-disabled patients, early-stage cancer was more frequently diagnosed in patients with disabilities during their regular hospital visits than in those without disabilities, who had more opportunity for early cancer detection during cancer screening. According to in-house data reflecting treatment period and process from a single hospital, all 16 disabled patients treated with chemotherapy completed the treatment until disease progression or end of predetermined cycles.
These results indicate that deep disparities between cancer patients with and without disabilities are not apparent and that the disabled patients in the region of northwestern Japan receive appropriate hospital follow-up.
在日本,残疾癌症患者与非残疾癌症患者之间潜在的差异仍有待验证。
我们调查了医院癌症登记的回顾性数据以及通过北信癌症数据库获得的残疾证明信息。2010年至2015年期间,日本西北部地区10家主要医院的93545名癌症患者在北信癌症数据库中进行了登记。该数据库包括以下数据:诊断日期、癌症类型、分期、治疗、癌症检测过程以及是否持有残疾证明。
我们发现2983名患者(占患者总数的3.2%)患有残疾。残疾患者与非残疾患者在性别、诊断时年龄、癌症分期分布和癌症发病率方面未观察到显著差异。尽管残疾患者中早期癌症的比例与非残疾患者仅略有不同,但残疾患者在定期医院就诊时比非残疾患者更频繁地被诊断出早期癌症,非残疾患者在癌症筛查期间有更多机会进行早期癌症检测。根据一家医院反映治疗期和治疗过程的内部数据,所有16名接受化疗的残疾患者均完成了治疗,直至疾病进展或预定周期结束。
这些结果表明,残疾癌症患者与非残疾癌症患者之间的巨大差异并不明显,并且日本西北部地区的残疾患者得到了适当的医院随访。